ANSUN BIOPHARMA, INC. — Form D
ANSUN BIOPHARMA, INC. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-05-29. The offering totals $24.3M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-05-29
- Form: D
- Accession: 0001534671-13-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $24.3M
- Amount sold: $5.0M
- Remaining: $19.3M
- Investors: 9
- Date of first sale: 2013-04-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-197200
Issuer
- Name: ANSUN BIOPHARMA, INC.
- CIK: 0001534671
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Address: 3030 CALLAN ROAD, SUITE 200, SAN DIEGO, CA, 92121
- Phone: 8584522631
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| MICHAEL CHAO | Executive Officer | SAN DIEGO, CA |
| RON MOSS | Executive Officer | SAN DIEGO, CA |
| Michael Chang | Director | Singapore, U0 |
| Yi Shi | Director | George Town, Grand Cayman, E9 |
| Dave Chenn | Director | Mountain View, CA |
| Nancy Chang | Director | Houston, TX |
| Nancy Chang | Executive Officer | Houston, TX |
| KAREN LIU | Director | SAN DIEGO, CA |
| AIMIN WU | Director | SAN DIEGO, CA |
| DONALD PAYNE | Director | SAN DIEGO, CA |
| MICHAEL CHAO | Director | SAN DIEGO, CA |
| Yining Zhao | Executive Officer | SAN DIEGO, CA |
| ALLEN CHAO | Director | SAN DIEGO, CA |
| MIKAEL HAVLUCIYAN | Executive Officer | SAN DIEGO, CA |
| Shi Yi | Director | San Diego, CA |
| Michael Havluciyan | Executive Officer | San Diego, CA |
| RONALD MOSS | Executive Officer | SAN DIEGO, CA |
| MARK ATTEBURY | Executive Officer | SAN DIEGO, CA |
Other filings by this issuer (7)
More